Literature DB >> 7391523

Variations in serum copper and ceruloplasmin activity following a long term intake of combined oral contraceptives in Iranian women.

S Kamyab, A Baghdiantz, S Jenati.   

Abstract

Serum copper level and ceruloplasmin activity were measured in 104 middle class Iranian women from 17 to 49 years of age, using combined oral contraceptives from 3 to 108 months, and results were compared with those obtained from 24 normal individuals (21-45 years of age) from the same social class. Significant increases were observed in 100% of test subjects in serum copper level and ceruloplasmin activity (p less than 0.005), which tend to decline following 48 months of intake, when liver probably adapts itself, and ceruloplasmin synthesis is not aggravated significantly any more. The variations observed in this study were higher than those obtained in Nigerian women and were comparable with those found in women from other countries.

Entities:  

Keywords:  Age Factors; Asia; Biology; Clinical Research; Contraception; Contraceptive Methods; Developing Countries; Family Planning; Hematological Effects; Hemic System; Iran; Oral Contraceptives; Oral Contraceptives, Combined; Physiology; Research Methodology; Serum Copper Level; Socioeconomic Status; Southern Asia

Mesh:

Substances:

Year:  1980        PMID: 7391523     DOI: 10.1007/BF03348246

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  Plasma-zinc and copper in pregnancy and after oral contraceptives.

Authors:  J A Halsted; B M Hackley; J C Smith
Journal:  Lancet       Date:  1968-08-03       Impact factor: 79.321

2.  Serum levels of copper, caeruloplasmin and caeruloplasmin oxidase activity in women using copper-containing intrauterine devices and in women taking combined oral contraceptives.

Authors:  B Daunter; M Elstein
Journal:  J Obstet Gynaecol Br Commonw       Date:  1973-07

3.  Copper levels in women using intrauterine devices or oral contraceptives.

Authors:  F Hefnawi; O Kandil; H Askalani; K Zaki; F Nasr; M Mousa
Journal:  Fertil Steril       Date:  1974-07       Impact factor: 7.329

4.  Serum copper alteration after ingestion of an oral contraceptive.

Authors:  J A O'Leary; W N Spellacy
Journal:  Science       Date:  1968-11-08       Impact factor: 47.728

5.  The effect of oral contraceptives on serum copper levels in Nigerian women.

Authors:  D A Olatunbosun; F A Adeniyi; B K Adadevoh
Journal:  J Obstet Gynaecol Br Commonw       Date:  1973-10

6.  Zinc and copper levels in pregnant women and those taking oral contraceptives. A preliminary report.

Authors:  J A O'Leary; W N Spellacy
Journal:  Am J Obstet Gynecol       Date:  1969-01-01       Impact factor: 8.661

7.  Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride.

Authors:  K H Schosinsky; H P Lehmann; M F Beeler
Journal:  Clin Chem       Date:  1974-12       Impact factor: 8.327

8.  Serum protein concentrations in pregnancy. 3. Analysis of maternal-cord serum pairs.

Authors:  H W Mendenhall
Journal:  Am J Obstet Gynecol       Date:  1970-03       Impact factor: 8.661

9.  Raised serum copper and caeruloplasmin levels in subjects taking oral contraceptives.

Authors:  M E Carruthers; C B Hobbs; R L Warren
Journal:  J Clin Pathol       Date:  1966-09       Impact factor: 3.411

10.  Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.

Authors:  M K Horwitt; C C Harvey; C H Dahm
Journal:  Am J Clin Nutr       Date:  1975-04       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.